Literature DB >> 18839139

Science, medicine and industry: are we getting out of the black hole in sepsis research?

Peter M Suter, Jukka Takala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18839139     DOI： 10.1007/s00134-008-1302-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  28 in total

1.  How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

2.  Tidal volumes in acute respiratory distress syndrome--one size does not fit all.

Authors:  Roy Brower; B Taylor Thompson
Journal:  Crit Care Med       Date:  2006-01       Impact factor: 7.598

3.  Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols.

Authors:  Katherine J Deans; Peter C Minneci; Anthony F Suffredini; Robert L Danner; William D Hoffman; Xizhong Ciu; Harvey G Klein; Alan N Schechter; Steven M Banks; Peter Q Eichacker; Charles Natanson
Journal:  Crit Care Med       Date:  2007-06       Impact factor: 7.598

4.  Pharmaceutical promotion to physicians and First Amendment rights.

Authors:  Aaron S Kesselheim; Jerry Avorn
Journal:  N Engl J Med       Date:  2008-04-17       Impact factor: 91.245

5.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

6.  Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

Authors:  R V McCloskey; R C Straube; C Sanders; S M Smith; C R Smith
Journal:  Ann Intern Med       Date:  1994-07-01       Impact factor: 25.391

7.  Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial.

Authors:  Steven Opal; Pierre-Francois Laterre; Edward Abraham; Bruno Francois; Xavier Wittebole; Stephen Lowry; Jean-Francois Dhainaut; Brian Warren; Thierry Dugernier; Angel Lopez; Miguel Sanchez; Ignace Demeyer; Luis Jauregui; Jose Angel Lorente; William McGee; Konrad Reinhart; Sascha Kljucar; Sonia Souza; John Pribble
Journal:  Crit Care Med       Date:  2004-02       Impact factor: 7.598

8.  Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.

Authors:  Angel López; Jose Angel Lorente; Jay Steingrub; Jan Bakker; Angela McLuckie; Sheila Willatts; Michael Brockway; Antonio Anzueto; Laurent Holzapfel; Desmond Breen; Michael S Silverman; Jukka Takala; Jill Donaldson; Carl Arneson; Geraldine Grove; Steven Grossman; Robert Grover
Journal:  Crit Care Med       Date:  2004-01       Impact factor: 7.598

9.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

Authors:  Frank M Brunkhorst; Christoph Engel; Frank Bloos; Andreas Meier-Hellmann; Max Ragaller; Norbert Weiler; Onnen Moerer; Matthias Gruendling; Michael Oppert; Stefan Grond; Derk Olthoff; Ulrich Jaschinski; Stefan John; Rolf Rossaint; Tobias Welte; Martin Schaefer; Peter Kern; Evelyn Kuhnt; Michael Kiehntopf; Christiane Hartog; Charles Natanson; Markus Loeffler; Konrad Reinhart
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

10.  Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock.

Authors:  Simon Finfer; V Marco Ranieri; B Taylor Thompson; Philip S Barie; Jean-François Dhainaut; Ivor S Douglas; Bengt Gårdlund; John C Marshall; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2008-10-07       Impact factor: 17.440
View more
  3 in total

1.  Prolonging resuscitation and postponing the death of activated protein C or is it?

Authors:  Kaggere Shivalingaiah Paramesh; Jim Zwaal
Journal:  Intensive Care Med       Date:  2009-01-09       Impact factor: 17.440

2.  Editors' comments on a new trial of activated protein C for persistent septic shock.

Authors:  Jordi Mancebo; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2008-10-07       Impact factor: 17.440

Review 3.  Year in review in Intensive Care Medicine, 2008: I. Brain injury and neurology, renal failure and endocrinology, metabolism and nutrition, sepsis, infections and pneumonia.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2008-12-09       Impact factor: 17.440
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.